Andromeda Surgical raises $15 million to push autonomy into prostate surgery
Standard Capital led the round as Andromeda runs an international clinical trial of its tablet-controlled Beacon robotic platform.
By Ryan Merket · Published
Primary source: X
Why it matters
Andromeda is testing whether a focused, software-first robot can introduce autonomy to surgery without the hardware budgets and long timelines associated with incumbent systems.
Nick Damiano and Kartik Tiwari, co-founders of Andromeda Surgical, announced in an August 3rd post that the surgical robotics developer raised a $15 million Series A led by Standard Capital. Y Combinator and VOX Capital also participated.…
When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.